4.6 Review

HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biology

Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction

Shuhei Suzuki et al.

Summary: Dexamethasone can sensitize cancer stem cells to chemotherapeutic agents by promoting chemotherapy-induced ROS production through suppressing NRF2 expression.

LIFE-BASEL (2021)

Article Gastroenterology & Hepatology

Nrf2 expression in pancreatic stellate cells promotes progression of cancer

Yu Tanaka et al.

Summary: Systemic Nrf2 deletion decreases pancreatic cancer progression in a mutant K-ras/p53-expressing mouse model, with pancreatic stellate cells (PSCs) playing a role in this process. Nrf2-deleted PSCs exhibit lower proliferative and migration capacity, and show reduced growth-stimulating effects on pancreatic cancer cells.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)

Article Cell Biology

ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer

Vinee Purohit et al.

Summary: The overexpression of ATDC in pancreatic cancer promotes tumor growth and metastasis by protecting cancer cells from ROS through stabilizing NRF2. This mechanism enhances chemoresistance and modulates redox balance in cancer cells.

GENES & DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

Macrophage peroxiredoxin 5 deficiency promotes lung cancer progression via ROS-dependent M2-like polarization

Jung Bae Seong et al.

Summary: This study revealed that deficiency of the antioxidant enzyme peroxiredoxin 5 (Prx5) in macrophages induced M2 macrophage polarization, promoting lung cancer progression. However, suppression of ROS generation by N-acetyl cysteine (NAC) inhibited the M2-like polarization of Prx5-deficient macrophages, leading to inhibition of lung cancer cell proliferation and migration, and suppression of tumor growth. These findings suggest that blocking the M2 polarization of macrophages may promote lung cancer regression.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Cell Biology

Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis

Alina Kuper et al.

Summary: The hypoxia-induced resistance of tumor cells to therapeutic treatment is influenced by the PERK-NRF2-HIF axis, with NRF2 playing a crucial role in proliferation, ROS elimination, and radioprotection under constant hypoxia. Depletion of NRF2 does not affect apoptosis, cell cycle progression, and proliferation factors, but eliminates cellular HIF-1 alpha signaling. These findings provide new insights into the complex interactions within tumor cells.

CELL DEATH & DISEASE (2021)

Review Oncology

The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment

Keiko Taguchi et al.

Summary: The KEAP1-NRF2 system attracts extensive interest in cancer research due to NRF2's dual activity as an oncogene and tumor suppressor. NRF2-addicted cancers exhibit high NRF2 expression and somatic mutations stabilize and accumulate NRF2. These cancers hijack NRF2's cytoprotective roles to survive in harsh microenvironments.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition

Shin Hamada et al.

Summary: Research has shown that Nrf2 activation and glutaminase inhibition may have potential therapeutic effects on K-ras mutant pancreatic cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma

Kaiyuan Chen et al.

Summary: DMF shows promise as a potential novel therapy for cancer treatment by modulating antioxidant pathways and suppressing cell growth in pancreatic cancer.

FRONTIERS IN PHARMACOLOGY (2021)

Review Oncology

Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches

Tiago M. A. Carvalho et al.

Summary: PDAC has a poor prognosis due to the lack of early diagnosis, suitable biomarkers, and resistance to available therapies. The desmoplastic stroma in PDAC compromises treatments by reprogramming cellular metabolism, leading to impaired response to therapy. Understanding the mechanisms of PDAC resistance is crucial for improving patient outcomes.

CANCERS (2021)

Review Oncology

Synthetic Lethality in Cancer Therapeutics: The Next Generation

Jeremy Setton et al.

Summary: Synthetic lethality (SL) provides a theoretical framework for targeting loss-of-function mutations in tumor suppressor genes and DNA repair genes, as well as amplification and/or overexpression of genes that cannot be directly targeted. The emergence of next generation tumor-specific alterations targetable through SL from high-throughput CRISPR technology presents new opportunities for drug development, but also brings important challenges in developing optimal predictive biomarkers.

CANCER DISCOVERY (2021)

Article Oncology

MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer

Qiangsheng Hu et al.

Summary: The study reveals that MTAP deficiency drives pancreatic cancer progression by inducing metabolic reprogramming, offering a new target and therapeutic strategy for treating MTAP-deficient disease. The findings also suggest that MTAP status impacts glucose and purine metabolism, identifying multiple novel treatment options against MTAP-deficient pancreatic cancer.

CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

Vittoria Infantino et al.

Summary: In cancer cells, metabolic reprogramming under low-oxygen conditions is crucial for tumor survival, with HIF-1 playing a pivotal role. Mitochondria are key players in regulating cellular energy and closely interact with HIF-1 to drive metabolic and functional changes in cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia

Matias Estaras et al.

Summary: The study demonstrates that melatonin at pharmacological concentrations can diminish the proliferation of pancreatic stellate cells subjected to hypoxia by modulating the cell cycle, apoptosis, and the activation of crucial MAPKs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

Pancreatic Cancer: A Review

Wungki Park et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer with increasing incidence each year, resulting in a high percentage of patients being diagnosed with advanced disease. Current cytotoxic therapies for PDAC are moderately effective, emphasizing the importance of multidisciplinary management, comprehensive germline testing, and integrated supportive care for all patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Pharmacology & Pharmacy

Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression

Ryotaro Matsumoto et al.

Summary: Our study identified halofuginone as a therapeutic agent for Nrf2-activated pancreatic cancers by depleting Nrf2 and downregulating ALDH3A1, sensitizing cancer cells to gemcitabine. This suggests Nrf2 and its downstream target ALDH3A1 as novel therapeutic targets in pancreatic cancer, affecting gemcitabine efficacy. Our findings confirm the pivotal role of Nrf2 in the regulation of ALDH3A1.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Article Cell Biology

Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

Bingbing Dai et al.

Summary: This study identified a novel compound NSLC01 that selectively targets NRF2-activated pancreatic cancer cells, inducing significant anticancer effects, especially in cells with high NRF2 activation. NSLC01 induces apoptosis in cancer cells by inhibiting protein translation and suppressing de novo synthesis of amino acids, leading to synthetic lethal effects in NRF2-activated pancreatic cancers.

CELL DEATH & DISEASE (2021)

Review Medicine, Research & Experimental

The double-edged roles of ROS in cancer prevention and therapy

Yawei Wang et al.

Summary: Reactive oxygen species (ROS) act as cell signaling molecules generated in oxidative metabolism and are associated with various human diseases. Abnormal accumulation of ROS in cancer cells leads to tumor progression and metastasis. Understanding the dual roles of ROS in tumor growth, metastasis, and apoptosis, as well as related signal transduction networks and anticancer therapies is crucial in conquering cancer.

THERANOSTICS (2021)

Article Gastroenterology & Hepatology

Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma

Tatsuhide Nabeshima et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

Review Gastroenterology & Hepatology

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

Takuji Okusaka et al.

JOURNAL OF GASTROENTEROLOGY (2020)

Review Biochemistry & Molecular Biology

The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway

Liam Baird et al.

MOLECULAR AND CELLULAR BIOLOGY (2020)

Article Endocrinology & Metabolism

Hypoxia Increases β-Cell Death by Activating Pancreatic Stellate Cells within the Islet

Jong Jin Kim et al.

DIABETES & METABOLISM JOURNAL (2020)

Article Multidisciplinary Sciences

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer

Matteo Morotti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer

X. P. Cao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Oncology

Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis

Yasuyuki Mizutani et al.

CANCER RESEARCH (2019)

Review Cell Biology

Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review

Jiang-Jiang Qin et al.

CELL COMMUNICATION AND SIGNALING (2019)

Article Gastroenterology & Hepatology

Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma

Shin Hamada et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)

Article Multidisciplinary Sciences

A catalogue of somatic NRF2 gain-of-function mutations in cancer

Michael John Kerins et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation

Kouhei Tsuchida et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Review Biochemistry & Molecular Biology

Oxygen availability and metabolic reprogramming in cancer

Hong Xie et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Oncology

The KeAP1-NRF2 System in Cancer

Keiko Taguchi et al.

FRONTIERS IN ONCOLOGY (2017)

Article Oncology

Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis

Shin Hamada et al.

CARCINOGENESIS (2017)

Article Biochemistry & Molecular Biology

Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

Anju Singh et al.

ACS CHEMICAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Iok In Christine Chio et al.

Article Gastroenterology & Hepatology

IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells

Shin Hamada et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Review Cell Biology

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer

Lun Zhang et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Article Biochemistry & Molecular Biology

Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma

Na Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Oncology

Oxygen availability and metabolic adaptations

Michael S. Nakazawa et al.

NATURE REVIEWS CANCER (2016)

Review Gastroenterology & Hepatology

Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer

Atsushi Masamune et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)

Review Oncology

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis

Florent Morfoisse et al.

MOLECULAR & CELLULAR ONCOLOGY (2015)

Editorial Material Biochemistry & Molecular Biology

MicroRNAs in Hypoxia Response

Simona Greco et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Review Biochemistry & Molecular Biology

Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways

Fabienne Guillaumond et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)

Article Biochemistry & Molecular Biology

Pancreatic stellate cells reduce insulin expression and induce apoptosis in pancreatic β-cells

Kazuhiro Kikuta et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

miR-210 regulates the interaction between pancreatic cancer cells and stellate cells

Tetsuya Takikawa et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Oxidative stress plays a role in high glucose-induced activation of pancreatic stellate cells

Gyeong Ryul Ryu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Surgery

Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells

Thomas A. Mace et al.

JOURNAL OF SURGICAL RESEARCH (2013)

Article Multidisciplinary Sciences

CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

Albrecht Neesse et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells

Shin Hamada et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Article Oncology

KrasG12D and p53 Mutation Cause Primary intrahepatic Cholangiocarcinoma

Michael R. O'Dell et al.

CANCER RESEARCH (2012)

Article Gastroenterology & Hepatology

StellaTUM: current consensus and discussion on pancreatic stellate cell research

Mert Erkan et al.

Article Multidisciplinary Sciences

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

Gina M. De Nicola et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells

Kazuhiro Kikuta et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Multidisciplinary Sciences

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Shinichi Yachida et al.

NATURE (2010)

Article Gastroenterology & Hepatology

Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer

Atsushi Masamune et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)

Article Gastroenterology & Hepatology

NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells

Atsushi Masamune et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)

Article Immunology

Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts

K. -H. Hong et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)

Article Gastroenterology & Hepatology

Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase

M Edderkaoui et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)

Article Physiology

Hypoxic induction of Ctgf is directly mediated by Hif-1

DF Higgins et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)

Article Pharmacology & Pharmacy

Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells

A Masamune et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)

Article Oncology

Pancreatic tumors show high levels of hypoxia

AC Koong et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)